Neumora Therapeutics NMRA
NASDAQ NMRA
$0.47 +0.01 (+1.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Neumora Therapeutics (NMRA) Receivables - Other (2022 - 2024)

Updated

Neumora Therapeutics (NMRA) reported Receivables - Other of $1.63 million for Q2 2024, up 80.0% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Receivables - Other (2022 - 2024) Analysis & Trends

At the end of FY2023, Neumora Therapeutics posted Receivables - Other of $939,000, up 2.2% from FY2022.

  • By year, Receivables - Other came in at $919,000 in FY2022.
  • Per Business Quant data, the three quarters before Q2 2024 came in at $906,000 (Q1 2024), $939,000 (Q4 2023) and $668,000 (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Neumora Therapeutics 88.31 Mn -529.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 1.63 Mn
Mar 31, 2024 906,000.00
Dec 31, 2023 939,000.00
Sep 30, 2023 668,000.00
Dec 31, 2022 919,000.00
API Access

Neumora Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=NMRA&period=max&api_key=YOUR_API_KEY